In this GEN webinar, we will learn current methodology for using Micro-Flow Imaging (MFI) to assess size and agglomeration of PLGA microparticles—since MFI is able to differentiate between fines, ...

Have you met MFI? Micro-flow imaging is a new solution for measuring and visualizing subvisible particles in biopharmaceutical products. As these small (1-1,000 micron) particles are considered a ...

Development of safe and effective protein therapeutics relies on the accurate assessment of the amount, type, and size distribution of particle impurities within the formulation. Precise ...

Sub-visible particles are a critical quality attribute for pharmaceutical products, as protein aggregates can elicit an immunogenic response that affects the therapeutic's efficacy. Measuring protein ...

In 2016, the FDA identified particulate matter contamination as the second leading cause of product recalls. Current contaminant detection techniques, such as light obscuration (LO), are restricted in ...